Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c76ecadad74a1a35270b3e3a34d60f37 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0362 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-8509 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-0275 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2002-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d02e9cb2a6f955fcbf572eb547ca0d71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f432a9c17b1540e66d832c926afc19eb |
publicationDate |
2002-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2002360120-A |
titleOfInvention |
Transgenic animals containing dominant negative mutant P1-3 kinase p85 subunit |
abstract |
(57) Abstract: A transgenic animal comprising a dominant negative mutant form of a regulatory phosphatidylinositol-3 kinase p85 subunit. The present invention relates to a genetically modified non-human mammal having an altered body fat composition, wherein the exogenous mutant p85 PI3-K gene expression is driven by an insulin-responsive cell-specific promoter. Related to animals. The present invention also relates to transgenic cell lines containing the same mutant gene, and methods of using these animals and / or cells. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10190171-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10196692-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014171413-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8901285-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-5761914-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9863003-B2 |
priorityDate |
2001-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |